Provider POV: 340B is Critical. We Must Raise Our Voices.
In the wake of abounding 340B changes, Dr. Christopher Hall gives a provider’s POV on the program’s impact and why sharing success stories is critical to its future.
In the wake of abounding 340B changes, Dr. Christopher Hall gives a provider’s POV on the program’s impact and why sharing success stories is critical to its future.
Finding the right 340B partner is no walk in the park. Industry experts offer the top three considerations for selecting a solutions provider that will deliver.
During a tumultuous time for covered entities, tech-driven engagement, intelligence, and trust will help drive the next phase of American health. Here’s how.
The LGBTQ+ community is facing an unprecedented degradation of their health equity and civil rights. Here’s why the time for silent support is over.
Stephen Massey has mobilized the private sector to solve global problems for two decades. Now he’s bringing businesses together to end HIV in the U.S.
Avita’s Glen Pietrandoni and Lee Horner offer no-holds-barred insights on the intersection of telehealth and onsite care in this edition of “The Take.”
A lack of strategic marketing can keep a covered entity from fulfilling its mission. Avita’s Glen Pietrandoni & Liz Eckert offer five tips for engaging patients.
What’s behind Avita’s recent expansion and brand refresh? It’s all about helping patients and partners remove barriers to care, CEO Michael Yount explains.
Avita’s growth into a health care services organization reinforces our dedication to reducing health inequities. Here’s how.
Dr. Eugene McCray has been at the forefront of the fight to end HIV/AIDS since its inception. Here’s what he’s learned along the way.
Ensuring the true value of the 340B program is fully understood has never been more critical. Here’s why and how covered entities can easily get involved.
The 30-year champion of HIV prevention and treatment, LGBTQ+ rights, and the 340B program will lead the next chapter of Avita’s advocacy efforts.
At the 340B Coalition Summer Conference, Avita Board Member Dr. Jerome Adams offered advice on supporting the drug discount program’s future. Read on for insights from 340B Report.
As PrEP turns 10, advocate Jim Pickett discusses the early years and what’s coming next. “We’ve come a long way, baby. But there’s so much work to do.”
Covered entities must grow their patient bases to successfully sustain their missions. Learn why and glean actionable insights from industry experts.